TY - JOUR
T1 - Prostaglandin in the ventromedial hypothalamus regulates peripheral glucose metabolism
AU - Lee, Ming Liang
AU - Matsunaga, Hirokazu
AU - Sugiura, Yuki
AU - Hayasaka, Takahiro
AU - Yamamoto, Izumi
AU - Ishimoto, Taiga
AU - Imoto, Daigo
AU - Suematsu, Makoto
AU - Iijima, Norifumi
AU - Kimura, Kazuhiro
AU - Diano, Sabrina
AU - Toda, Chitoku
N1 - Funding Information:
This work was supported by Leading Initiative for Excellent Young Researchers (from MEXT); a Grant-in-Aid for Young Scientists (A) (Grant Number JP17H05059), a Grant-in-Aid for Scientific Research (B) (Grant Number JP18H02857); Japanese Initiative for Progress of Research on Infectious Diseases for Global Epidemics (JP17fm0208011h0001, JP18fm0208011h0002, JP19fm0208011h0003); the Takeda Science Foundation; the Uehara Memorial Foundation; Astellas Foundation for Research on Metabolic Disorders; Suzuken Memorial Foundation; Program for supporting introduction of the new sharing system (JPMXS0420100617, JPMXS0420100618, JPMXS0420100619) and National Institutes of Health (RO1 DK107293). Infrastructure of LC-MS was supported by JST ERATO Suematsu Gas Biology Project. M.S. is the lead until March 2015.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12/1
Y1 - 2021/12/1
N2 - The hypothalamus plays a central role in monitoring and regulating systemic glucose metabolism. The brain is enriched with phospholipids containing poly-unsaturated fatty acids, which are biologically active in physiological regulation. Here, we show that intraperitoneal glucose injection induces changes in hypothalamic distribution and amounts of phospholipids, especially arachidonic-acid-containing phospholipids, that are then metabolized to produce prostaglandins. Knockdown of cytosolic phospholipase A2 (cPLA2), a key enzyme for generating arachidonic acid from phospholipids, in the hypothalamic ventromedial nucleus (VMH), lowers insulin sensitivity in muscles during regular chow diet (RCD) feeding. Conversely, the down-regulation of glucose metabolism by high fat diet (HFD) feeding is improved by knockdown of cPLA2 in the VMH through changing hepatic insulin sensitivity and hypothalamic inflammation. Our data suggest that cPLA2-mediated hypothalamic phospholipid metabolism is critical for controlling systemic glucose metabolism during RCD, while continuous activation of the same pathway to produce prostaglandins during HFD deteriorates glucose metabolism.
AB - The hypothalamus plays a central role in monitoring and regulating systemic glucose metabolism. The brain is enriched with phospholipids containing poly-unsaturated fatty acids, which are biologically active in physiological regulation. Here, we show that intraperitoneal glucose injection induces changes in hypothalamic distribution and amounts of phospholipids, especially arachidonic-acid-containing phospholipids, that are then metabolized to produce prostaglandins. Knockdown of cytosolic phospholipase A2 (cPLA2), a key enzyme for generating arachidonic acid from phospholipids, in the hypothalamic ventromedial nucleus (VMH), lowers insulin sensitivity in muscles during regular chow diet (RCD) feeding. Conversely, the down-regulation of glucose metabolism by high fat diet (HFD) feeding is improved by knockdown of cPLA2 in the VMH through changing hepatic insulin sensitivity and hypothalamic inflammation. Our data suggest that cPLA2-mediated hypothalamic phospholipid metabolism is critical for controlling systemic glucose metabolism during RCD, while continuous activation of the same pathway to produce prostaglandins during HFD deteriorates glucose metabolism.
UR - http://www.scopus.com/inward/record.url?scp=85104677477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104677477&partnerID=8YFLogxK
U2 - 10.1038/s41467-021-22431-6
DO - 10.1038/s41467-021-22431-6
M3 - Article
C2 - 33879780
AN - SCOPUS:85104677477
SN - 2041-1723
VL - 12
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 2330
ER -